254 related articles for article (PubMed ID: 20920768)
1. Risk of perinatal mortality associated with inhaled corticosteroid use for the treatment of asthma during pregnancy.
Breton MC; Beauchesne MF; Lemière C; Rey É; Forget A; Blais L
J Allergy Clin Immunol; 2010 Oct; 126(4):772-777.e2. PubMed ID: 20920768
[TBL] [Abstract][Full Text] [Related]
2. Risk of perinatal mortality associated with asthma during pregnancy.
Breton MC; Beauchesne MF; Lemière C; Rey E; Forget A; Blais L
Thorax; 2009 Feb; 64(2):101-6. PubMed ID: 19008298
[TBL] [Abstract][Full Text] [Related]
3. Inhaled corticosteroids during pregnancy: a review of methodologic issues.
Breton MC; Martel MJ; Vilain A; Blais L
Respir Med; 2008 Jun; 102(6):862-75. PubMed ID: 18342498
[TBL] [Abstract][Full Text] [Related]
4. Impact of maternal use of asthma-controller therapy on perinatal outcomes.
Cossette B; Forget A; Beauchesne MF; Rey É; Lemière C; Larivée P; Battista MC; Blais L
Thorax; 2013 Aug; 68(8):724-30. PubMed ID: 23585516
[TBL] [Abstract][Full Text] [Related]
5. Risk of congenital malformations for asthmatic pregnant women using a long-acting β₂-agonist and inhaled corticosteroid combination versus higher-dose inhaled corticosteroid monotherapy.
Eltonsy S; Forget A; Beauchesne MF; Blais L
J Allergy Clin Immunol; 2015 Jan; 135(1):123-30. PubMed ID: 25226849
[TBL] [Abstract][Full Text] [Related]
6. Relationship between changes in inhaled corticosteroid use and markers of uncontrolled asthma during pregnancy.
Blais L; Firoozi F; Kettani FZ; Ducharme FM; Lemière C; Beauchesne MF; Bérard A
Pharmacotherapy; 2012 Mar; 32(3):202-9. PubMed ID: 22392453
[TBL] [Abstract][Full Text] [Related]
7. Use of inhaled corticosteroids during the first trimester of pregnancy and the risk of congenital malformations among women with asthma.
Blais L; Beauchesne MF; Rey E; Malo JL; Forget A
Thorax; 2007 Apr; 62(4):320-8. PubMed ID: 17121872
[TBL] [Abstract][Full Text] [Related]
8. Risk of perinatal mortality associated with asthma during pregnancy: a 2-stage sampling cohort study.
Breton MC; Beauchesne MF; Lemière C; Rey E; Forget A; Blais L
Ann Allergy Asthma Immunol; 2010 Sep; 105(3):211-7. PubMed ID: 20800787
[TBL] [Abstract][Full Text] [Related]
9. The relationship of asthma medication use to perinatal outcomes.
Schatz M; Dombrowski MP; Wise R; Momirova V; Landon M; Mabie W; Newman RB; Hauth JC; Lindheimer M; Caritis SN; Leveno KJ; Meis P; Miodovnik M; Wapner RJ; Paul RH; Varner MW; O'Sullivan MJ; Thurnau GR; Conway DL; ;
J Allergy Clin Immunol; 2004 Jun; 113(6):1040-5. PubMed ID: 15208581
[TBL] [Abstract][Full Text] [Related]
10. Beta2-agonists use during pregnancy and the risk of congenital malformations.
Eltonsy S; Forget A; Blais L
Birth Defects Res A Clin Mol Teratol; 2011 Nov; 91(11):937-47. PubMed ID: 21948561
[TBL] [Abstract][Full Text] [Related]
11. Doubling daily inhaled corticosteroid dose is ineffective in mild to moderately severe attacks of asthma in adults.
Rice-McDonald G; Bowler S; Staines G; Mitchell C
Intern Med J; 2005 Dec; 35(12):693-8. PubMed ID: 16313543
[TBL] [Abstract][Full Text] [Related]
12. Psychosocial outcomes are related to asthma control and quality of life in pregnant women with asthma.
Powell H; McCaffery K; Murphy VE; Hensley MJ; Clifton VL; Giles W; Gibson PG
J Asthma; 2011 Dec; 48(10):1032-40. PubMed ID: 22091740
[TBL] [Abstract][Full Text] [Related]
13. Effect of fetal gender on maternal asthma exacerbations in pregnant asthmatic women.
Firoozi F; Ducharme FM; Lemière C; Beauchesne MF; Perreault S; Forget A; Blais L
Respir Med; 2009 Jan; 103(1):144-51. PubMed ID: 18760909
[TBL] [Abstract][Full Text] [Related]
14. Fetal glucocorticoid-regulated pathways are not affected by inhaled corticosteroid use for asthma during pregnancy.
Hodyl NA; Stark MJ; Osei-Kumah A; Bowman M; Gibson P; Clifton VL
Am J Respir Crit Care Med; 2011 Mar; 183(6):716-22. PubMed ID: 20935111
[TBL] [Abstract][Full Text] [Related]
15. Effect of inhaled glucocorticoid treatment on placental 11beta-hydroxysteroid dehydrogenase type 2 activity and neonatal birthweight in pregnancies complicated by asthma.
Clifton VL; Rennie N; Murphy VE
Aust N Z J Obstet Gynaecol; 2006 Apr; 46(2):136-40. PubMed ID: 16638036
[TBL] [Abstract][Full Text] [Related]
16. Use of short-acting beta2-agonists during pregnancy and the risk of pregnancy-induced hypertension.
Martel MJ; Rey E; Beauchesne MF; Perreault S; Forget A; Maghni K; Lefebvre G; Blais L
J Allergy Clin Immunol; 2007 Mar; 119(3):576-82. PubMed ID: 17166573
[TBL] [Abstract][Full Text] [Related]
17. Agreement between administrative databases and medical charts for pregnancy-related variables among asthmatic women.
Vilain A; Otis S; Forget A; Blais L
Pharmacoepidemiol Drug Saf; 2008 Apr; 17(4):345-53. PubMed ID: 18271060
[TBL] [Abstract][Full Text] [Related]
18. Association between previous health care use and initiation of inhaled corticosteroid and long-acting beta2-adrenergic agonist combination therapy among US patients with asthma.
Blanchette CM; Culler SD; Ershoff D; Gutierrez B
Clin Ther; 2009 Nov; 31(11):2574-83. PubMed ID: 20110003
[TBL] [Abstract][Full Text] [Related]
19. Inhaled glucocorticoids during pregnancy and offspring pediatric diseases: a national cohort study.
Tegethoff M; Greene N; Olsen J; Schaffner E; Meinlschmidt G
Am J Respir Crit Care Med; 2012 Mar; 185(5):557-63. PubMed ID: 22198975
[TBL] [Abstract][Full Text] [Related]
20. Inhaled corticosteroid use and outcomes in pregnancy.
Schatz M; Leibman C
Ann Allergy Asthma Immunol; 2005 Sep; 95(3):234-8. PubMed ID: 16200813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
